Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic neuropathic pain. Spinal cord stimulation devices reduce the need for opioid-based pain ...

However, concerns regarding softness in the spinal cord stimulation ... aimed at treating chronic pain caused by the SI joint, a common source of lower back pain, Nevro seeks to address a ...

Nevro Corp. engages in the development ... patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based ...

According to the newly published report, “ The Market for Implanted Pain Neuromodulation Systems: 2025-2030,” the worldwide ...

In September 2024, Nevro gained approval from the US Food and Drug Administration (FDA) for HFX AdaptivAI, a personalised pain management ... s Wavewriter spinal cord stimulator systems, for ...